Integrated BioPharma, Inc. financial statements
Integrated BioPharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 43.87M | 10-K |
| Net income | −USD 2.84M | 10-K |
| Cash and equivalents | USD 4.47M | 10-Q |
Integrated BioPharma, Inc. financials on 6ix · Integrated BioPharma, Inc. on 6ix